Related Experiment Video
Updated: Jun 20, 2026

06:31
Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Quantitative patch and repeated open application testing in hydroxyisohexyl 3-cyclohexene carboxaldehyde
Axel Schnuch1, Wolfgang Uter, Heinrich Dickel
1Information Network of Departments of Dermatology, University of Göttingen, Göttingen/Germany. aschnuch@med.uni-goettingen.de
Contact Dermatitis
|September 29, 2009
Summary
To prevent allergic reactions, the safe concentration of hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) in products for sensitized individuals is below 0.027%. This research helps establish safe usage levels for HICC in cosmetics.
Area of Science:
- Dermatology
- Toxicology
- Cosmetic Science
Background:
- Hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) is a common fragrance ingredient.
- Allergic contact dermatitis is a significant concern with fragrance compounds.
- Establishing safe concentration limits for sensitized individuals is crucial for consumer safety.
Purpose of the Study:
- To determine the maximum concentration of HICC that does not elicit an allergic reaction in patients with known sensitization.
- To provide data for setting safe usage levels of HICC in cosmetic products.
Main Methods:
- Repeated Open Application Testing (ROAT) on 64 sensitized subjects using HICC in perfume and cream formulations at varying concentrations (0.005-2.5%).
- Confirmatory patch testing with HICC preparations at 2.5% and 5% concentrations.
- Statistical analysis to correlate ROAT results with patch test sensitivity and specificity.
Main Results:
- Estimated tolerable HICC concentrations for 90% of sensitized individuals were <88.2 ppm for cream and <270 ppm for perfume.
- Patch test sensitivity ranged from 88.5-98.1%, with specificity from 37.5-87.5%.
- A significant inverse correlation was found between ROAT concentrations and patch test reaction strength, indicating varying susceptibility levels.
Conclusions:
- Recommended use concentrations to protect 90% of sensitized individuals range from 0.009% to 0.027%, varying by product type.
- Avoiding excessive HICC concentrations is essential to prevent further sensitization.
- Continuous monitoring is necessary to validate the effectiveness of HICC exposure recommendations.
